Advertisement
Screener

PHATHOM PHARMACEUTICALS, INC. (PHAT) Pre-Tax Margin

Phathom Pharmaceuticals, Inc. Pre-Tax Margin

Pre-tax margin is the percentage of revenue left as profit after every expense except income tax. It is income before income tax divided by revenue, and the table shows both amounts beside the percentage. It sits between operating margin and net margin: it includes interest and other non-operating items but not the tax charge, so the gap down to net margin is the tax burden. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Phathom Pharmaceuticals, Inc. pre-tax margin for fiscal 2025 was -126.35%, a change of 478.75% from fiscal 2024.
  • Phathom Pharmaceuticals, Inc. pre-tax margin for fiscal 2024 was -605.09%.
Available history
2024-12-31 to 2025-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue

Annual Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2025-12-31-126.35%-$221.25M$175.11M
2024-12-31-605.09%-$334.33M$55.25M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Evolus, Inc. (EOLS)United States$0.519B-13.32
Neurogene Inc. (NGNE)$0.625B-4.46